Poseida Therapeutics, Inc. Depreciation and Amortization Expense
Poseida Therapeutics, Inc. reported Depreciation and Amortization Expense of $1.30 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DepreciationAndAmortization · last filed 2024-11-07
- Poseida Therapeutics, Inc. depreciation, depletion and amortization, nonproduction for the quarter ending 2024-09-30 was $1.30M, a 7.14% decline year-over-year.
- Poseida Therapeutics, Inc. depreciation, depletion and amortization, nonproduction for the quarter ending 2024-06-30 was $1.30M, a 7.14% decline year-over-year.
- Poseida Therapeutics, Inc. depreciation, depletion and amortization, nonproduction for the quarter ending 2024-03-31 was $1.38M, a 4.23% increase year-over-year.
- Poseida Therapeutics, Inc. depreciation, depletion and amortization, nonproduction for the quarter ending 2023-12-31 was $1.44M, a 5.90% increase year-over-year.
- Poseida Therapeutics, Inc. depreciation, depletion and amortization, nonproduction for fiscal 2023 was $5.61M, a 8.55% increase from fiscal 2022.
- Poseida Therapeutics, Inc. depreciation, depletion and amortization, nonproduction for fiscal 2022 was $5.17M, a 13.62% increase from fiscal 2021.
- Poseida Therapeutics, Inc. depreciation, depletion and amortization, nonproduction for fiscal 2021 was $4.55M, a 76.02% increase from fiscal 2020.
- Poseida Therapeutics, Inc. depreciation, depletion and amortization, nonproduction for fiscal 2020 was $2.59M, a 116.76% increase from fiscal 2019.
| Period end | Depreciation, Depletion and Amortization, Nonproduction 3 month | Depreciation, Depletion and Amortization, Nonproduction 6 month | Depreciation, Depletion and Amortization, Nonproduction 6 month as first filed | Depreciation, Depletion and Amortization, Nonproduction 9 month | Depreciation, Depletion and Amortization, Nonproduction 9 month as first filed | Depreciation, Depletion and Amortization, Nonproduction 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $1.30M 10-Q · filed 2024-11-07 | $2.60M derived: sum of 2 quarters · filed 2024-11-07 | $4.05M 10-Q · filed 2024-11-07 | $5.42M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2024-06-30 | $1.30M 10-Q · filed 2024-08-05 | $2.73M 10-Q · filed 2024-08-05 | $4.12M derived: sum of 3 quarters · filed 2024-08-05 | $5.51M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2024-03-31 | $1.38M 10-Q · filed 2024-05-14 | $2.81M derived: sum of 2 quarters · filed 2024-05-14 | $4.21M derived: sum of 3 quarters · filed 2024-11-07 | $5.62M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $2.83M derived: sum of 2 quarters · filed 2024-11-07 | $4.24M derived: sum of 3 quarters · filed 2024-11-07 | $5.61M 10-K · filed 2024-03-07 | ||
| 2023-09-30 | $1.40M 10-Q · filed 2024-11-07 | $2.80M derived: sum of 2 quarters · filed 2024-11-07 | $4.18M 10-Q · filed 2024-11-07 | $4.18M 10-Q · filed 2023-11-09 | $5.48M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $1.40M 10-Q · filed 2024-08-05 | $2.73M 10-Q · filed 2024-08-05 | $2.73M 10-Q · filed 2023-08-08 | $4.08M derived: sum of 3 quarters · filed 2024-08-05 | $5.48M derived: sum of 4 quarters · filed 2024-08-05 | |
| 2023-03-31 | $1.32M 10-Q · filed 2024-05-14 | $2.68M derived: sum of 2 quarters · filed 2024-05-14 | $4.08M derived: sum of 3 quarters · filed 2024-05-14 | $5.38M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $2.75M derived: sum of 2 quarters · filed 2024-03-07 | $4.05M derived: sum of 3 quarters · filed 2024-03-07 | $5.17M 10-K · filed 2024-03-07 | ||
| 2022-09-30 | $1.40M 10-Q · filed 2023-11-09 | $2.70M derived: sum of 2 quarters · filed 2023-11-09 | $3.82M 10-Q · filed 2023-11-09 | $5.09M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $1.30M 10-Q · filed 2023-08-08 | $2.47M 10-Q · filed 2023-08-08 | $3.69M derived: sum of 3 quarters · filed 2023-08-08 | $4.89M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $1.21M 10-Q · filed 2023-05-09 | $2.39M derived: sum of 2 quarters · filed 2023-05-09 | $3.59M derived: sum of 3 quarters · filed 2023-05-09 | $4.69M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.38M derived: sum of 2 quarters · filed 2023-03-09 | $3.48M derived: sum of 3 quarters · filed 2023-03-09 | $4.55M 10-K · filed 2023-03-09 | ||
| 2021-09-30 | $1.20M 10-Q · filed 2022-11-10 | $2.30M derived: sum of 2 quarters · filed 2022-11-10 | $3.37M 10-Q · filed 2022-11-10 | $4.41M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $1.10M 10-Q · filed 2022-08-11 | $2.20M 10-Q · filed 2022-08-11 | $3.21M derived: sum of 3 quarters · filed 2022-08-11 | $3.91M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $1.07M 10-Q · filed 2022-05-12 | $2.11M derived: sum of 2 quarters · filed 2022-05-12 | $2.81M derived: sum of 3 quarters · filed 2022-05-12 | $3.31M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.74M derived: sum of 2 quarters · filed 2022-03-10 | $2.24M derived: sum of 3 quarters · filed 2022-03-10 | $2.59M 10-K · filed 2022-03-10 | ||
| 2020-09-30 | $700.00K 10-Q · filed 2021-11-09 | $1.20M derived: sum of 2 quarters · filed 2021-11-09 | $1.55M 10-Q · filed 2021-11-09 | $2.00M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $500.00K 10-Q · filed 2021-08-12 | $859.00K 10-Q · filed 2021-08-12 | $1.30M derived: sum of 3 quarters · filed 2021-08-12 | $1.65M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $416.00K 10-Q · filed 2021-05-11 | $802.00K derived: sum of 2 quarters · filed 2021-05-11 | $1.15M derived: sum of 3 quarters · filed 2021-05-11 | |||
| 2019-12-31 | $386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $733.00K derived: sum of 2 quarters · filed 2021-03-11 | $1.19M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | $347.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $807.00K 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | $460.00K 10-Q · filed 2020-08-20 |